The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria

Abstract

Addition of biomarkers representing diverse carcinogenic pathways can significantly impact on the ROC statistic based on demographics. Benign prostate hyperplasia was a significant confounding pathology and identification of nonmuscle invasive urothelial cancer remains a challenge.